In contrast, we showed that myeloid FoxO1 deficiency protected mice from developing diet-induced inflammation and insulin resistance, a beneficial effect that halted the progression of NAFL to NASH in MøFoxO1-KO mice on a NASH diet. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatohepatitis.